Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pneumonia × Prednisone × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Thymoma 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Radiation Pneumonitis 1 Pneumonia 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Melanoma 1 Lung Diseases, Interstitial 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colitis 1 Carcinoma, Renal Cell 1 Advanced Squamous Non Small Cell Lung Cancer 1 Adenocarcinoma 1

Interventions

Ultrasonography 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Sodium Bicarbonate 1 Saline Solution 1 Prednisone 1 Nebulizers and Vaporizers 1 Lidocaine 1 Fluoridation 1 Clinical Protocols 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡